Braidwell LP
- SEC CIK
- 0001920938
- Latest filing
- Aug 14, 2026
Holdings in Q1 2024
Holdings as of Mar 31, 2024, filed May 15, 2024. Long positions only; changes compare share counts with Q4 2023.
- Positions
- 70
- −2 vs. Q4 2023
- Portfolio value
- $3.10B
- +$380.1M (+14.0%) vs. Q4 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| HROWHarrow, Inc. | COM | 125,967 | $1.67M | 0.1% | −1,372,617−91.6% | Reduced | History |
| ADPTAdaptive Biotechnologies Corp | COM | 1,357,490 | $4.36M | 0.1% | 00.0% | Unchanged | History |
| OMOutset Medical, Inc. | COM | 2,400,427 | $5.33M | 0.2% | 00.0% | Unchanged | History |
| Cutera Inc232109AD0 | NOTE 2.250% 6/0 | – | $5.74M | 0.2% | – | – | – |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 7,843,285 | $5.93M | 0.2% | 00.0% | Unchanged | History |
| Cutera Inc232109AG3 | NOTE 4.000% 6/0 | – | $6.44M | 0.2% | – | – | – |
| LUNGPulmonx Corp | COM | 752,541 | $6.98M | 0.2% | −35,413−4.5% | Reduced | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 704,344 | $7.97M | 0.3% | +704,344 | New | History |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 609,643 | $9.59M | 0.3% | −559,847−47.9% | Reduced | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 660,022 | $9.78M | 0.3% | +660,022 | New | History |
| BBIOBridgeBio Pharma, Inc. | COM | 344,827 | $10.7M | 0.3% | +344,827 | New | History |
| ELEVElevation Acquisition Group Inc. | COM | 2,377,647 | $12.2M | 0.4% | +2,377,647 | New | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 1,300,000 | $12.9M | 0.4% | +1,300,000 | New | History |
| ALECAlector, Inc. | COM | 2,380,704 | $14.3M | 0.5% | −943,604−28.4% | Reduced | History |
| MLYSMineralys Therapeutics, Inc. | COM | 1,147,154 | $14.8M | 0.5% | −876,746−43.3% | Reduced | History |
| ITOSiTeos Therapeutics, Inc. | COM | 1,162,374 | $15.9M | 0.5% | +1,162,374 | New | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 3,379,577 | $17.2M | 0.6% | −2,338,900−40.9% | Reduced | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 435,823 | $18.7M | 0.6% | +155,665+55.6% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 218,896 | $19.1M | 0.6% | +218,896 | New | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 515,000 | $19.5M | 0.6% | 00.0% | Unchanged | History |
| Haemonetics Corp Mass405024AB6 | NOTE 3/0 | – | $19.8M | 0.6% | – | New | – |
| Ironwood Pharmaceuticals Inc46333XAF5 | NOTE 0.750% 6/1 | – | $19.9M | 0.6% | – | – | – |
| LXEOLexeo Therapeutics, Inc. | COM | 1,322,277 | $20.7M | 0.7% | +1,322,277 | New | History |
| TRMLTourmaline Bio, Inc. | COM | 906,820 | $20.8M | 0.7% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,240,865 | $21.1M | 0.7% | 00.0% | Unchanged | History |
| INSPInspire Medical Systems, Inc. | COM | 101,492 | $21.8M | 0.7% | −83,166−45.0% | Reduced | History |
| NVRONevro Corp | COM | 1,776,368 | $25.7M | 0.8% | 00.0% | Unchanged | History |
| RGENRepligen Corp | COM | 142,836 | $26.3M | 0.8% | +40,138+39.1% | Added | History |
| TMOThermo Fisher Scientific Inc. | Stock | 47,149 | $27.4M | 0.9% | −28,600−37.8% | Reduced | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 1,392,716 | $27.5M | 0.9% | +1,392,716 | New | History |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 3,489,843 | $30.4M | 1.0% | +3,489,843 | New | History |
| RLAYRelay Therapeutics, Inc. | COM | 3,743,999 | $31.1M | 1.0% | +3,743,999 | New | History |
| KRYSKrystal Biotech, Inc. | COM | 177,089 | $31.5M | 1.0% | −19,111−9.7% | Reduced | History |
| KIDSOrthopediatrics Corp | COM | 1,107,770 | $32.3M | 1.0% | 00.0% | Unchanged | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 1,052,485 | $33.5M | 1.1% | +1,052,485 | New | History |
| Alphatec Hldgs Inc02081GAB8 | NOTE 0.750% 8/0 | – | $33.9M | 1.1% | – | – | – |
| Karyopharm Therapeutics Inc.48576UAA4 | NOTE 3.000%10/1 | – | $35.8M | 1.2% | – | – | – |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 2,173,704 | $35.9M | 1.2% | −2,041,869−48.4% | Reduced | History |
| ISRGIntuitive Surgical Inc | COM NEW | 100,500 | $40.1M | 1.3% | +100,500 | New | History |
| FNAParagon 28, Inc. | COM | 3,365,609 | $41.6M | 1.3% | +3,785+0.1% | Added | History |
| GKOSGLAUKOS Corp | COM | 450,676 | $42.5M | 1.4% | +207,916+85.6% | Added | History |
| AVDLAvadel Pharmaceuticals PLC | SPONSORED ADR | 2,668,549 | $45.1M | 1.5% | +2,668,549 | New | History |
| TMDXTransMedics Group, Inc. | COM | 614,531 | $45.4M | 1.5% | +496,830+422.1% | Added | History |
| KROSKeros Therapeutics, Inc. | COM | 737,379 | $48.8M | 1.6% | −381,582−34.1% | Reduced | History |
| CGONCG Oncology, Inc. | COM | 1,130,235 | $49.6M | 1.6% | +1,130,235 | New | History |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $49.6M | 1.6% | – | – | – |
| GHGuardant Health, Inc. | COM | 2,476,804 | $51.1M | 1.6% | +1,717,876+226.4% | Added | History |
| Ironwood Pharmaceuticals Inc46333XAH1 | NOTE 1.500% 6/1 | – | $53.7M | 1.7% | – | – | – |
| BridgeBio Pharma, Inc.10806XAD4 | NOTE 2.250% 2/0 | – | $55.1M | 1.8% | – | – | – |
| ALGNAlign Technology Inc | COM | 169,252 | $55.5M | 1.8% | +22,939+15.7% | Added | History |
| IRTCiRhythm Holdings, Inc. | COM | 483,257 | $56.1M | 1.8% | −84,900−14.9% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 1,308,011 | $56.3M | 1.8% | −339,300−20.6% | Reduced | History |
| VKTXViking Therapeutics, Inc. | COM | 713,100 | $58.5M | 1.9% | +713,100 | New | History |
| Sarepta Therapeutics, Inc.803607AD2 | NOTE 1.250% 9/1 | – | $59.3M | 1.9% | – | – | – |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 7,221,960 | $62.6M | 2.0% | +2,181,325+43.3% | Added | History |
| PENPenumbra Inc | COM | 295,892 | $66.0M | 2.1% | +73,100+32.8% | Added | History |
| Insulet Corp45784PAK7 | NOTE 0.375% 9/0 | – | $68.9M | 2.2% | – | – | – |
| INSMED Inc457669AA7 | NOTE 1.750% 1/1 | – | $69.4M | 2.2% | – | – | – |
| LEGNLegend Biotech Corp | SPONSORED ADS | 1,243,795 | $69.8M | 2.2% | +681,195+121.1% | Added | History |
| Dexcom Inc252131AK3 | NOTE 0.250%11/1 | – | $71.6M | 2.3% | – | – | – |
| Neogenomics Inc64049MAB6 | NOTE 0.250% 1/1 | – | $82.6M | 2.7% | – | – | – |
| PCVXVaxcyte, Inc. | COM | 1,212,703 | $82.8M | 2.7% | −77,262−6.0% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 219,824 | $86.5M | 2.8% | +66,620+43.5% | Added | History |
| NBIXNeurocrine Biosciences Inc | Stock | 730,209 | $100.7M | 3.2% | +15,000+2.1% | Added | History |
| Nuvasive Inc670704AJ4 | NOTE 0.375% 3/1 | – | $109.0M | 3.5% | – | – | – |
| APGEApogee Therapeutics, Inc. | COM | 1,842,515 | $122.4M | 3.9% | +1,161,414+170.5% | Added | History |
| NovoCure Ltd67011XAB9 | NOTE 11/0 | – | $124.6M | 4.0% | – | – | – |
| Exact Sciences Corp30063PAC9 | NOTE 0.375% 3/0 | – | $133.1M | 4.3% | – | – | – |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $146.2M | 4.7% | – | – | – |
| Guardant Health, Inc.40131MAB5 | NOTE 11/1 | – | $183.6M | 5.9% | – | – | – |
Sold out since Q4 2023 (19)
Positions held at the end of Q4 2023 that are gone from this filing.
| Security | Class | Shares in Q4 2023 | Value in Q4 2023 | % of portfolio in Q4 2023 | History |
|---|---|---|---|---|---|
| Ascendis Pharma A/S04351PAD3 | NOTE 2.250% 4/0 | – | $130.4M | 4.8% | – |
| Tandem Diabetes Care Inc875372AB0 | NOTE 1.500% 5/0 | – | $67.2M | 2.5% | – |
| IMCRImmunocore Holdings plc | ADS | 611,365 | $41.8M | 1.5% | History |
| LNTHLantheus Holdings, Inc. | Stock | 495,100 | $30.7M | 1.1% | History |
| AMGNAmgen Inc | Stock | 58,200 | $16.8M | 0.6% | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 2,318,050 | $15.0M | 0.6% | History |
| Invitae Corp46185LAB9 | NOTE 2.000% 9/0 | – | $14.9M | 0.5% | – |
| THRDThird Harmonic Bio, Inc. | COM | 1,316,018 | $14.4M | 0.5% | History |
| Travere Therapeutics, Inc.89422GAA5 | NOTE 2.250% 3/0 | – | $11.1M | 0.4% | – |
| MRUSMerus N.V. | COM | 370,679 | $10.2M | 0.4% | History |
| DYNDyne Therapeutics, Inc. | COM | 755,811 | $10.1M | 0.4% | History |
| DNLIDenali Therapeutics Inc. | COM | 461,769 | $9.91M | 0.4% | History |
| RAPTRAPT Therapeutics, Inc. | COM | 389,300 | $9.67M | 0.4% | History |
| Neogenomics Inc64049MAA8 | NOTE 1.250% 5/0 | – | $9.38M | 0.3% | – |
| VRDNViridian Therapeutics, Inc. | COM | 323,102 | $7.04M | 0.3% | History |
| Ionis Pharmaceuticals Inc462222AD2 | NOTE 4/0 | – | $5.54M | 0.2% | – |
| HLVXHilleVax, Inc. | COM | 203,407 | $3.26M | 0.1% | History |
| Nanostring Technologies Inc63009RAD1 | NOTE 2.625% 5/0 | – | $2.72M | 0.1% | – |
| CMPXCompass Therapeutics, Inc. | COM | 317,761 | $495.7K | <0.1% | History |